These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19635008

  • 1. Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
    Dickmann P, Keith K, Comer C, Abraham G, Gopal R, Marui E.
    Biosecur Bioterror; 2009 Jun; 7(2):227-33. PubMed ID: 19635008
    [Abstract] [Full Text] [Related]

  • 2. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC, Alderman TS, Blair HA, Brocard AS, Broussard EE, Ellis RP, Frerotte J, Low EW, McCarthy TR, McCormick JM, Newton JM, Rogers FC, Schlimgen R, Stabenow JM, Stedman D, Warfield C, Ntiforo CA, Whetstone CT, Zimmerman D, Barkley E.
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [Abstract] [Full Text] [Related]

  • 3. Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication.
    Dickmann P, Apfel F, Biedenkopf N, Eickmann M, Becker S.
    Health Secur; 2015 Mar; 13(2):88-95. PubMed ID: 25813975
    [Abstract] [Full Text] [Related]

  • 4. Good and bad examples of siting and building biosafety level 4 laboratories: a study of Winnipeg, Galveston and Etobicoke.
    Löfstedt R.
    J Hazard Mater; 2002 Jul 01; 93(1):47-66. PubMed ID: 12062953
    [Abstract] [Full Text] [Related]

  • 5. Lessons to be Learned from Recent Biosafety Incidents in the United States.
    Weiss S, Yitzhaki S, Shapira SC.
    Isr Med Assoc J; 2015 May 01; 17(5):269-73. PubMed ID: 26137650
    [Abstract] [Full Text] [Related]

  • 6. Biological safety in the medical laboratory.
    Lo J.
    Hong Kong Med J; 2015 Jun 01; 21(3):200. PubMed ID: 26045068
    [No Abstract] [Full Text] [Related]

  • 7. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    Centers for Disease Control and Prevention, Gangadharan D, Smith J, Weyant R.
    MMWR Recomm Rep; 2013 Jun 28; 62(RR-06):1-7. PubMed ID: 23803973
    [Abstract] [Full Text] [Related]

  • 8. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K, Holbrook MR, Adams R, Barr J, Bollinger L, Newton JT, Ntiforo C, Coe L, Wada J, Pusl D, Jahrling PB, Kuhn JH, Lackemeyer MG.
    J Vis Exp; 2016 Oct 03; (116):. PubMed ID: 27768063
    [Abstract] [Full Text] [Related]

  • 9. Communication and computing technology in biocontainment laboratories using the NEIDL as a model.
    McCall J, Hardcastle K.
    Pathog Dis; 2014 Jul 03; 71(2):96-101. PubMed ID: 24535887
    [Abstract] [Full Text] [Related]

  • 10. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
    Shurtleff AC, Garza N, Lackemeyer M, Carrion R, Griffiths A, Patterson J, Edwin SS, Bavari S.
    Viruses; 2012 Dec 03; 4(12):3932-51. PubMed ID: 23342380
    [Abstract] [Full Text] [Related]

  • 11. Standard practice for cell sorting in a BSL-3 facility.
    Perfetto SP, Ambrozak DR, Nguyen R, Roederer M, Koup RA, Holmes KL.
    Methods Mol Biol; 2011 Dec 03; 699():449-69. PubMed ID: 21116997
    [Abstract] [Full Text] [Related]

  • 12. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
    Mourya DT, Yadav PD, Majumdar TD, Chauhan DS, Katoch VM.
    Indian J Med Res; 2014 Aug 03; 140(2):171-83. PubMed ID: 25297350
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories.
    Race MS, Hammond E.
    Biosecur Bioterror; 2008 Mar 03; 6(1):19-35. PubMed ID: 18386970
    [Abstract] [Full Text] [Related]

  • 14. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S, Jacob D, Rohleder AM, Bråve A, Szekely Björndal Å, Di Caro A, Grunow R, Joint Action EMERGE laboratory networkThe EMERGE partners are acknowledged at the end of the article..
    Euro Surveill; 2020 Sep 03; 25(36):. PubMed ID: 32914748
    [Abstract] [Full Text] [Related]

  • 15. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT, Yadav PD, Khare A, Khan AH.
    Indian J Med Res; 2017 Oct 03; 146(4):459-467. PubMed ID: 29434059
    [Abstract] [Full Text] [Related]

  • 16. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
    Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A.
    Clin Microbiol Infect; 2017 Feb 03; 23(2):58-60. PubMed ID: 27404371
    [No Abstract] [Full Text] [Related]

  • 17. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN.
    Int J Antimicrob Agents; 2010 Nov 03; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [Abstract] [Full Text] [Related]

  • 18. U.S. Ebola Treatment Center Clinical Laboratory Support.
    Jelden KC, Iwen PC, Herstein JJ, Biddinger PD, Kraft CS, Saiman L, Smith PW, Hewlett AL, Gibbs SG, Lowe JJ.
    J Clin Microbiol; 2016 Apr 03; 54(4):1031-5. PubMed ID: 26842705
    [Abstract] [Full Text] [Related]

  • 19. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY, Xue KN, Jiang JS, Lu XC.
    Biomed Environ Sci; 2016 Apr 03; 29(4):300-4. PubMed ID: 27241742
    [Abstract] [Full Text] [Related]

  • 20. Framework for leadership and training of Biosafety Level 4 laboratory workers.
    Le Duc JW, Anderson K, Bloom ME, Estep JE, Feldmann H, Geisbert JB, Geisbert TW, Hensley L, Holbrook M, Jahrling PB, Ksiazek TG, Korch G, Patterson J, Skvorak JP, Weingartl H.
    Emerg Infect Dis; 2008 Nov 03; 14(11):1685-8. PubMed ID: 18976549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.